ESC 365 - Initiation of oral anticoagulation therapy in atrial fibrillation patients with schizophrenia: a nationwide cohort study

ESC Premium Access

Initiation of oral anticoagulation therapy in atrial fibrillation patients with schizophrenia: a nationwide cohort study

Session: Neuropsychiatric disease, substance abuse and the heart

Topic: Psychiatric Disorders and Heart Disease

Speaker: Doctor A. Hojen (Aalborg, DK)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Anette Arbjerg Hojen

Aalborg University Hospital, Aalborg (Denmark)

0 follower

6 more presentations in this session

Atrial fibrillation in elderly patients with syncope and dementia: clinical insights from a large multicenter Italian registry

Impaired left ventricular systolic function in alcohol abusers expressed by both 3D calculated ejection fraction and longitudinal strain by AFI.

Speaker: Doctor P. Hamala (Lodz, PL)

Patients with psychiatric disorders have reduced chances of receiving optimal post-arrest cardiovascular management

Speaker: Doctor C. Barcella (Copenhagen, DK)

Neurogenic stunned myoacardium in multiple sclerosis patients

Speaker: Doctor E. Tsougos (Athens, GR)

Clinical differences between methamphetamine and non-methamphetamine associated non-ischemic dilated cardiomyopathy.

Speaker: Doctor E. Chau (Los Angeles, US)

Access the full session

Neuropsychiatric disease, substance abuse and the heart

Speakers: Doctor A. Hojen, Doctor P. Hamala, Doctor C. Barcella, Doctor E. Tsougos, Doctor E. Chau

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources